The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment
Pharmaceuticals · 03.10.2023 · 16 (10) · 1405
DOI: 10.3390/ph16101405 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 03.10.2023. Verfasst von Ewa Dudzińska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dietetics and Nutrition Education, Medical University of Lublin, 20-093 Lublin, Poland. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.
Abstract (Originalsprache)
The visceral stimuli from the digestive tract are transmitted via afferent nerves through the spinal cord to the brain, where they are felt as pain. The overreaction observed in the brain of irritable bowel syndrome (IBS) patients may be due to increased peripheral sensitivity to stimuli from the gastrointestinal tract. Although the exact pathway is uncertain, attenuation of visceral hypersensitivity is still of interest in treating IBS. It has been shown that stress stimulates the sympathetic nervous system while inhibiting the vagus nerve (VN). In addition, stress factors lead to dysbiosis and chronic low-grade inflammation of the intestinal mucosa, which can lead to lower gastrointestinal visceral hypersensitivity. Therefore, an important goal in the treatment of IBS is the normalization of the intestinal microflora. An interesting option seems to be nutraceuticals, including Terminalia chebula, which has antibacterial and antimicrobial activity against various pathogenic Gram-positive and Gram-negative bacteria. Additionally, short-term transcutaneous vagus nerve stimulation can reduce the stress-induced increase in intestinal permeability, thereby reducing inflammation. The conducted studies also indicate a relationship between the stimulation of the vagus nerve (VN) and the activation of neuromodulatory networks in the central nervous system. Therefore, it seems reasonable to conclude that a two-way action through stimulating the VN and using nutraceuticals may become an effective therapy in treating IBS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dietetics and Nutrition Education, Medical University of Lublin, 20-093 Lublin, Poland.
- Department of Biological Sciences, University of Limerick, V94 PH61 Limerick, Ireland.
- Bernal Institute, University of Limerick, V94 PH61 Limerick, Ireland.
- Health Research Institute (HRI), University of Limerick, V94 PH61 Limerick, Ireland.
- Department of Diagnostic Immunology, Pomeranian Medical University in Szczecin, Al. Powstancow Wlkp. 72, 70-111 Szczecin, Poland.
- Department of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland.
ORCID-Profile: Ewa Dudzińska, Andreas M Grabrucker, Paweł Kwiatkowski, Robert Sitarz, Monika Sienkiewicz
Förderung
- Medical University of Lublin
Zitieren
APA
Dudzińska, E., Grabrucker, A. M., Kwiatkowski, P., Sitarz, R., & Sienkiewicz, M. (2023). The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment. Pharmaceuticals, 16(10), 1405. https://doi.org/10.3390/ph16101405
Vancouver
Dudzińska E, Grabrucker AM, Kwiatkowski P, Sitarz R, Sienkiewicz M. The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment. Pharmaceuticals. 2023;16(10):1405. doi:10.3390/ph16101405
BibTeX
@article{Dudziska2023,
author = {Dudzińska, Ewa and Grabrucker, Andreas M and Kwiatkowski, Paweł and Sitarz, Robert and Sienkiewicz, Monika},
title = {The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {10},
pages = {1405},
doi = {10.3390/ph16101405}
}
EUVIMED